» Articles » PMID: 29933702

Developments with Investigating Descriptors for Antimicrobial AApeptides and Their Derivatives

Overview
Specialties Chemistry
Pharmacology
Date 2018 Jun 24
PMID 29933702
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The development of multidrug-resistant strains of bacteria resulting from prolonged treatment with conventional antibiotics has necessitated the need for continuous research for better antibiotic strategies. One of these alternatives is evolutionary antimicrobial peptides also known as host-defense peptides (HDPs). HDPs are an integral part of the innate defense system in multicellular eukaryotes. Although HDPs can largely circumvent the persistent problem of antibiotic resistance due to their bacteriolytic membrane mechanism, they have some drawbacks including a low activity profile and protease instability. AApeptides have recently been introduced as a new class of peptidomimetics with resistance to proteolysis, improved activity profile, and limitless possibilities for structural diversity. Furthermore, they have shown excellent antimicrobial activity. Areas covered: This review updates the reader on the latest developments of antimicrobial AApeptides, the various derivatizations, and their development for antimicrobial applications. The most recent findings on the heterogeneous γ-AA backbone are also outlined. Expert opinion: AApeptides have found diverse applications in antimicrobial studies. AApeptides are believed to exhibit bactericidal properties by imitating the membranolytic action of HDPs. They have shown broad-spectrum antimicrobial activity and are active against medicinally relevant drug-resistant pathogens. AApeptides and their derivatives could gain therapeutic relevance in the design and development of antibiotic agents.

Citing Articles

Exploiting gasdermin-mediated pyroptosis for enhanced antimicrobial activity of phage endolysin against .

Kuc-Ciepluch D, Ciepluch K, Augustyniak D, Gula G, Maciejewska B, Kowalik A mSystems. 2024; 10(1):e0110624.

PMID: 39714210 PMC: 11748493. DOI: 10.1128/msystems.01106-24.


Lipidated α/Sulfono-α-AA heterogeneous peptides as antimicrobial agents for MRSA.

Singh S, Wang M, Gao R, Teng P, Odom T, Zhang E Bioorg Med Chem. 2019; 28(1):115241.

PMID: 31812324 PMC: 10523340. DOI: 10.1016/j.bmc.2019.115241.

References
1.
Srinivas N, Jetter P, Ueberbacher B, Werneburg M, Zerbe K, Steinmann J . Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science. 2010; 327(5968):1010-3. DOI: 10.1126/science.1182749. View

2.
Teng P, Huo D, Nimmagadda A, Wu J, She F, Su M . Small Antimicrobial Agents Based on Acylated Reduced Amide Scaffold. J Med Chem. 2016; 59(17):7877-87. PMC: 5345128. DOI: 10.1021/acs.jmedchem.6b00640. View

3.
Ghosh C, Manjunath G, Akkapeddi P, Yarlagadda V, Hoque J, Uppu D . Small molecular antibacterial peptoid mimics: the simpler the better!. J Med Chem. 2014; 57(4):1428-36. DOI: 10.1021/jm401680a. View

4.
Li Y, Smith C, Wu H, Padhee S, Manoj N, Cardiello J . Lipidated cyclic γ-AApeptides display both antimicrobial and anti-inflammatory activity. ACS Chem Biol. 2013; 9(1):211-7. PMC: 3947011. DOI: 10.1021/cb4006613. View

5.
Obrecht D, Robinson J, Bernardini F, Bisang C, DeMarco S, Moehle K . Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics. Curr Med Chem. 2009; 16(1):42-65. DOI: 10.2174/092986709787002844. View